Bills before the Senate

Search all bills

Current Bills
Previous Bills

TOTAL RESULTS: 128

  • Date
    23 Jun 2015 
    Chamber
    Senate 
    Status
    Before Senate 
    Sponsor
    RHIANNON, Sen Lee 
    Summary
    Establishes the Office of Animal Welfare as an independent statutory authority with responsibility for advising on the protection of animal welfare in Commonwealth regulated activities; provides for the functions, appointment and terms and conditions of the Chief Executive Officer (CEO), and for staff and consultants; establishes the Office of Animal Welfare Advisory Committee to advise the CEO; and provides for reporting requirements. 

    Bill | Explanatory Memorandum

  • Date
    11 Nov 2015 
    Chamber
    Senate 
    Status
    Before Senate 
    Sponsor
    LAMBIE, Sen Jacqui 
    Summary
    Amends the
    Veterans’ Entitlements Act 1986
    to provide that all veterans, including former members of the Defence Force and members of a peacekeeping force, who have served in war or war-like operations, are eligible for medical treatment, regardless of whether the condition or injury was caused by war or contracted during war or war-like operations. 

    Bill | Explanatory Memorandum

  • Date
    19 Jun 2017 
    Chamber
    Senate 
    Status
    Before Senate 
    Sponsor
    LEYONHJELM, Sen David
    ROBERTS, Sen Malcolm 
    Summary
    Amends the:
    Airports Act 1996
    to provide that the regulation of smoking at airports does not apply to the use of e-cigarettes (vaping);
    Therapeutic Goods Act 1989
    to exclude e-cigarettes from regulation by the Therapeutic Goods Administration; and
    Tobacco Advertising Prohibition Act 1992
    to provide that the ban on the advertising of smoking does not apply to the advertising of vaping. 

    Bill | Explanatory Memorandum

  • Date
    17 Aug 2017 
    Chamber
    House of Representatives 
    Status
    Before Senate 
    Portfolio
    Treasury 
    Summary
    Part of a package of 11 bills to fund the Commonwealth’s contribution to the National Disability Insurance Scheme, the bill amends the
    Income Tax Assessment Act 1997
    to increase from 3 per cent to 3.5 per cent the rate of Medicare levy and Medicare levy surcharge component of the untainting tax rate. 

    Bill | Explanatory Memorandum

  • Date
    14 Sep 2017 
    Chamber
    House of Representatives 
    Status
    Before Senate 
    Portfolio
    Treasury 
    Summary
    Amends the
    Superannuation Guarantee (Administration) Act 1992
    to: provide that employees under workplace determinations or enterprise agreements made on or after 1 July 2018 have the right to choose their superannuation fund; and provide that amounts sacrificed under an employee salary sacrifice arrangement will not reduce an employer’s mandated superannuation guarantee contributions. 

    Bill | Explanatory Memorandum

  • Date
    14 Sep 2017 
    Chamber
    Senate 
    Status
    Before Senate 
    Portfolio
    Treasury 
    Summary
    Introduced with the Superannuation Laws Amendment (Strengthening Trustee Arrangements) Bill 2017, the bill amends the:
    Superannuation Industry (Supervision) Act 1993
    to: require trustees to assess on an annual basis whether the outcomes that are being delivered by MySuper products are promoting the financial interests of MySuper members; allow the Australian Prudential Regulation Authority (APRA) to refuse, or cancel, an authority to offer a MySuper product if it has a reason to believe the registrable superannuation entity (RSE) licensee may fail to comply with its obligations; impose civil and criminal penalties on directors of RSE licensees who fail to execute their responsibilities to act in the best interests of members, or who use their position to further their own interests to the detriment of members; enable APRA to refuse authority for a change in ownership or control where it has concerns about the person seeking ownership or control, give a direction to a person to relinquish control of a RSE licensee and remove or suspend an RSE licensee where it is subject to the control of its owner; align APRA’s directions powers in relation to the superannuation industry with its broader directions powers in the banking and insurance industries; and require RSE licensees to hold annual members’ meetings;
    Corporations Act 2001
    and
    Superannuation Industry (Supervision) Act 1993
    to require superannuation funds to disclose on a semi-annual basis investments that they hold directly or through associated entities and initial investments into non-associated entities;
    Financial Sector (Collection of Data) Act 2001
    to provide APRA with the ability to obtain information on expenses incurred by RSE and RSE licensees in managing or operating the RSE; and
    Australian Prudential Regulation Authority Act 1998
    to make consequential amendments. 

    Bill | Explanatory Memorandum

  • Date
    07 Dec 2017 
    Chamber
    Senate 
    Status
    Before Senate 
    Portfolio
    Treasury 

    Bill | Explanatory Memorandum

  • Date
    30 Mar 2017 
    Chamber
    House of Representatives 
    Status
    Before Senate 
    Portfolio
    Treasury 
    Summary
    Amends the:
    Income Tax Assessment Act 1936
    and
    Income Tax Assessment Act 1997
    to: supplement the ‘same business test’ with a ‘similar business test’ for the purposes of working out whether a company’s tax losses and net capital losses from previous income years can be used as a tax deduction in a current income year; and make consequential amendments; and
    Income Tax Assessment Act 1997
    to provide taxpayers with the choice to self-assess the effective life of certain intangible depreciating assets they start to hold on or after 1 July 2016. 

    Bill | Explanatory Memorandum

  • Date
    14 Sep 2017 
    Chamber
    House of Representatives 
    Status
    Before Senate 
    Portfolio
    Health 
    Summary
    Introduced with the Therapeutic Goods (Charges) Amendment Bill 2017, the bill amends the
    Therapeutic Goods Act 1989
    to: introduce a new approval pathway for prescription medicines by creating a class of therapeutic good to be known as ‘provisionally registered goods’; allow the minister to specify, by legislative instrument, permitted indications for use with listed medicines; establish an additional pathway for intermediate risk medicines through a new application and assessment process for sponsors of listed complementary medicines seeking to use indications that fall outside the permitted indications list; strengthen monitoring powers in relation to biologicals; implement stronger compliance and enforcement powers and graduated penalties for non-compliant behaviours; remove the distinctions between advertisements for therapeutic goods for which an approval is, or is not, required; enable the secretary to utilise the work of comparable overseas regulators in the course of making assessments of medical devices; enable the secretary to publish information in relation to Australian conformity assessment bodies; align the secretary’s powers relating to conformity assessment certificates issued by Australian conformity assessment bodies and conformity assessment certificates issued by the secretary; clarify that the secretary has the power to refuse an application for including medicines, biologicals and medical devices in the Australian Register of Therapeutic Goods prior to evaluating the application if it does not meet the application requirements; and make minor amendments to achieve consistency of regulatory requirements between different types of therapeutic goods and make other minor changes; and
    Broadcasting Services Act 1992
    to make consequential amendments. 

    Bill | Explanatory Memorandum

  • Date
    14 Sep 2017 
    Chamber
    House of Representatives 
    Status
    Before Senate 
    Portfolio
    Health 
    Summary
    Introduced with the Therapeutic Goods Amendment (2017 Measures No. 1) Bill 2017, the bill amends the
    Therapeutic Goods (Charges) Act 1989
    to: enable regulations to be made prescribing an annual charge for a conformity assessment body determination payable by the Australian corporation that is the subject of the determination; provide that the obligation for a conformity assessment body to pay an annual charge continues during a period in which the conformity assessment body determination is suspended; and ensure that the annual charges prescribed for provisionally registered goods also apply to provisionally registered goods entered in the Australian Register of Therapeutic Goods. 

    Bill | Explanatory Memorandum

Top